MEDNOW INC A - MDNWF STOCK NEWS

Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF), a Canadian virtual pharmacy, has engaged Gravitas Securities Inc. to offer senior secured convertible debentures, aiming to raise up to $3,000,000. Each Convertible Debenture will be priced at $1,000, bearing interest at 12% annually and maturing in 36 months. Holders can convert them into units at a price of $0.35 per unit, which includes common shares and purchase warrants. Funds will be used for strategic acquisitions and working capital. The offering is subject to TSXV approval.

Mednow Inc. (TSXV: MNOW, OTCQX: MDNWF) reported remarkable Q3 2022 growth, achieving a 225% quarter-over-quarter and 4,800% year-over-year revenue increase. With nine licensed pharmacies across Canada, the company emphasizes digital transformation in healthcare. Significant investments were made in technology and personnel, enhancing their proprietary CRM and patient app. Mednow also acquired Medvisit and established a specialty pharmacy network, positioning itself as a leader in virtual pharmacy services. Despite macroeconomic challenges, management believes the company is significantly undervalued.

Mednow has partnered with Aya, a health spending account company, to improve accessibility and affordability of pharmacy services for Aya members in Canada. As the Preferred Pharmacy Partner, Mednow offers discounts on prescription copayments through Aya's prepaid Mastercard®, reducing out-of-pocket expenses. This collaboration aims to enhance patient access to digital pharmacy care and health solutions, reflecting Mednow's commitment to innovative healthcare delivery. Mednow's approach includes free medication delivery, telemedicine services, and a digital interface for prescription management.

Mednow Inc. (TSXV:MNOW, OTCQX:MDNWF), a leading Canadian on-demand virtual pharmacy, will participate in the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022. The company aims to attract new investors and provide updates to existing stakeholders through a presentation available on demand for 30 days. Management will also engage in one-on-one and group meetings with institutional investors, highlighting its commitment to expanding its national presence in Canadian healthcare.

Mednow Inc. has launched a new pharmacy distribution center in Quebec, expanding its reach with fast, free prescription delivery. The 6,300 sq. ft. facility features virtual and in-person consultations, enhancing holistic patient care. Led by Director of Pharmacy Raji Al-Kurdi, Mednow aims to provide comprehensive services for chronic condition management. This expansion aligns with Mednow's goal to establish a national presence, supporting sustained business growth.

Mednow has partnered with HepCURE to eliminate hepatitis C in Canada by 2030. As part of this collaboration, Liver Care Canada will enhance patient access to HepCURE's treatment services, improving medication adherence and treatment outcomes. This partnership aims to expand Liver Care Canada's operations beyond Ontario to the rest of Canada, targeting marginalized populations. The integration of HepCURE's model has already shown success in Vancouver, with 91% of participants diagnosed and 80% linked to care.

Mednow reported a remarkable Q3/22 revenue increase of 225% quarter-over-quarter, reaching $6.14M, and over 4,800% year-over-year. The patient count also rose by 20% to approximately 23,000. Revenue forecasts for 2022 are set between C$42.5M to C$47.5M, with expectations for 2023 at C$105M to C$110M. The gross margin is projected to improve from 20% in 2022 to 25% in 2023. Moreover, Ali Reyhany will succeed Karim Nassar as CEO starting June 15, 2022.

Mednow Inc. (TSXV:MNOW, OTCQX:MDNWF), Canada’s on-demand virtual pharmacy, will present at Gravitas Securities Inc.’s 3rd Los Angeles Summit from June 21 to June 24, 2022 at the Beverly Hills Hotel. This event will attract a selective audience of venture capital, family office, and institutional investors from Canada and abroad. Mednow aims to introduce its story to potential investors and provide updates to existing ones. The company emphasizes its commitment to accessibility and quality healthcare through virtual pharmacy and telemedicine services.

Mednow Inc. (OTCQX:MDNWF), Canada's on-demand virtual pharmacy, has commenced trading on the OTCQX Best Market, enhancing its visibility to U.S. investors. This milestone simplifies the investment process by eliminating the need for a Canadian trading account. Mednow's shares will continue to trade on the TSX Venture Exchange under the symbol MNOW. The OTCQX Best Market is designed for established companies meeting high financial standards and robust corporate governance.